Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logothetis

Showing results (871-880 of 1,104) with videos related to

Pageof 111
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Cancer|October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 studyJohn C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cell|December 10, 2013
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockadeVivek K Arora, Emily Schenkein, Rajmohan Murali, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2019
Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychoticsStephen K Amoah, Brian A Rodriguez, Constantine N Logothetis, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 17, 2015
Ultrasmall Nanoplatforms as Calcium-Responsive Contrast Agents for Magnetic Resonance ImagingAlbert Moussaron, Sandip Vibhute, Andrea Bianchi, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
Scientific Reports|January 31, 2018
Regulation of Kv2.1 channel inactivation by phosphatidylinositol 4,5-bisphosphateMayra Delgado-Ramírez, José J De Jesús-Pérez, Iván A Aréchiga-Figueroa, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenograftsR A Newman, J Yang, M Raymond, et al.
Cells|April 14, 2019
Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic ImagingPrasanta Dutta, Travis C Salzillo, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potentialVasily J Assikis, Kim-Anh Do, Sijin Wen, et al.
Pageof 111

Showing results (871-880 of 1,104) with videos related to

Sort By:
Pageof 111
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trialBradley C Carthon, Jedd D Wolchok, Jianda Yuan, et al.
Cancer|October 7, 2011
Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 studyJohn C Araujo, Paul Mathew, Andrew J Armstrong, et al.
Cell|December 10, 2013
Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockadeVivek K Arora, Emily Schenkein, Rajmohan Murali, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 28, 2019
Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychoticsStephen K Amoah, Brian A Rodriguez, Constantine N Logothetis, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 17, 2015
Ultrasmall Nanoplatforms as Calcium-Responsive Contrast Agents for Magnetic Resonance ImagingAlbert Moussaron, Sandip Vibhute, Andrea Bianchi, et al.
Cancer Research|July 19, 2005
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived productsJeri Kim, Peiying Yang, Milind Suraokar, et al.
Scientific Reports|January 31, 2018
Regulation of Kv2.1 channel inactivation by phosphatidylinositol 4,5-bisphosphateMayra Delgado-Ramírez, José J De Jesús-Pérez, Iván A Aréchiga-Figueroa, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenograftsR A Newman, J Yang, M Raymond, et al.
Cells|April 14, 2019
Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic ImagingPrasanta Dutta, Travis C Salzillo, Shivanand Pudakalakatti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potentialVasily J Assikis, Kim-Anh Do, Sijin Wen, et al.
Pageof 111